213 related articles for article (PubMed ID: 2834625)
21. Administration of live varicella vaccine to children wtih leukaemia.
Brunell PA; Shehab Z; Geiser C; Waugh JE
Lancet; 1982 Nov; 2(8307):1069-73. PubMed ID: 6127546
[TBL] [Abstract][Full Text] [Related]
22. Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster.
van Loon AM; van der Logt JT; Heessen FW; Heeren MC; Zoll J
Epidemiol Infect; 1992 Feb; 108(1):165-74. PubMed ID: 1312479
[TBL] [Abstract][Full Text] [Related]
23. Reduction in the Number of Varicella-Zoster Virus-Specific T-Cells in Immunocompromised Children with Varicella.
Murata K; Hoshina T; Onoyama S; Tanaka T; Kanno S; Ishimura M; Koga Y; Nakayama H; Ohga S
Tohoku J Exp Med; 2020 Mar; 250(3):181-190. PubMed ID: 32213753
[TBL] [Abstract][Full Text] [Related]
24. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
Harper DR; Grose C
J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
[TBL] [Abstract][Full Text] [Related]
25. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
Jenke AC; Klein S; Baiker A; Wirth S; Sander M; Noelting C; Boecher O; Vizoso-Pinto MG
Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
27. Immunisation of nurses with a live varicella vaccine.
Ndumbe PM; Cradock-Watson JE; MacQueen S; Dunn H; Holzel H; André F; Davies EG; Dudgeon JA; Levinsky RJ
Lancet; 1985 May; 1(8438):1144-7. PubMed ID: 2860346
[TBL] [Abstract][Full Text] [Related]
28. Natural and artificial immunity to varicella zoster virus.
Ndumbe PM; Cradock-Watson J; Levinsky RJ
J Med Virol; 1988 Jun; 25(2):171-8. PubMed ID: 2839610
[TBL] [Abstract][Full Text] [Related]
29. The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content.
Bergen RE; Diaz PS; Arvin AM
J Infect Dis; 1990 Nov; 162(5):1049-54. PubMed ID: 2172393
[TBL] [Abstract][Full Text] [Related]
30. Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England.
Field N; Amirthalingam G; Waight P; Andrews N; Ladhani SN; van Hoek AJ; Maple PA; Brown KE; Miller E
Vaccine; 2014 Feb; 32(10):1213-7. PubMed ID: 23871823
[TBL] [Abstract][Full Text] [Related]
31. Immunity to varicella-zoster virus in a normal adult population.
Ndumbe PM; Macqueen S; Holzel H; Levinsky RJ
J Med Microbiol; 1985 Aug; 20(1):105-11. PubMed ID: 2991523
[TBL] [Abstract][Full Text] [Related]
32. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
Grose C
Mol Biol Med; 1989 Oct; 6(5):453-62. PubMed ID: 2560525
[TBL] [Abstract][Full Text] [Related]
33. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
[TBL] [Abstract][Full Text] [Related]
34. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
Sauerbrei A; Wutzler P
Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
[TBL] [Abstract][Full Text] [Related]
36. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.
Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE
J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630
[TBL] [Abstract][Full Text] [Related]
37. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients.
Asano Y; Itakura N; Hiroishi Y; Hirose S; Ozaki T; Kuno K; Nagai T; Yazaki T; Yamanishi K; Takahashi M
J Infect Dis; 1985 Nov; 152(5):863-8. PubMed ID: 2995510
[TBL] [Abstract][Full Text] [Related]
38. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
[TBL] [Abstract][Full Text] [Related]
39. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
Amlie-Lefond C; Gilden D
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
[TBL] [Abstract][Full Text] [Related]
40. Early results of a trial of the Oka-strain varicella vaccine in children with leukaemia or other malignancies in Sweden.
Heller L; Berglund G; Ahström L; Hellstrand K; Wahren B
Postgrad Med J; 1985; 61 Suppl 4():79-83. PubMed ID: 3014483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
